• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Centene Corporation (Amendment)

    2/9/24 8:50:19 AM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.4 CENTENE CORP COMMON STOCK Cusip #15135B101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #15135B101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 32,786,960 Item 6: 0 Item 7: 37,854,078 Item 8: 0 Item 9: 37,854,078 Item 11: 7.086% Item 12: HC Cusip #15135B101 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 37,854,078 Item 8: 0 Item 9: 37,854,078 Item 11: 7.086% Item 12: IN Item 1(a). Name of Issuer: CENTENE CORP Item 1(b). Address of Issuer's Principal Executive Offices: 7700 Forsyth Blvd. St. Louis, MO 63105 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 15135B101 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 37,854,078 (b) Percent of Class: 7.086% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 37,854,078 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CENTENE CORP. No one other person's interest in the COMMON STOCK of CENTENE CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2024 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC IA Fidelity Management Trust Company BK Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of CENTENE CORP at December 29, 2023. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $CNC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    7/28/2025$38.00Overweight → Neutral
    Cantor Fitzgerald
    7/23/2025$30.00Overweight → Equal Weight
    Wells Fargo
    7/21/2025$33.00Buy → Hold
    TD Cowen
    7/16/2025$30.00Neutral → Underperform
    BofA Securities
    7/10/2025$33.00Overweight → Equal-Weight
    Morgan Stanley
    7/2/2025$45.00Buy → Neutral
    UBS
    7/2/2025$48.00Overweight → Neutral
    Analyst
    6/9/2025$70.00Overweight
    Morgan Stanley
    More analyst ratings

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Burdick Kenneth A claimed ownership of 360,802 shares (SEC Form 3)

    3/A - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:37:15 PM ET
    $CNC
    Medical Specialities
    Health Care

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer London Sarah bought $490,365 worth of shares (19,230 units at $25.50), increasing direct ownership by 2% to 845,275 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    8/11/25 5:28:22 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Samuels Theodore R. Ii bought $248,580 worth of shares (9,000 units at $27.62) (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    7/29/25 6:01:58 PM ET
    $CNC
    Medical Specialities
    Health Care

    Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

    4 - CENTENE CORP (0001071739) (Issuer)

    12/19/24 5:39:30 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Centene downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Centene from Overweight to Neutral and set a new price target of $38.00

    7/28/25 8:33:52 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Centene from Overweight to Equal Weight and set a new price target of $30.00

    7/23/25 7:38:36 AM ET
    $CNC
    Medical Specialities
    Health Care

    Centene downgraded by TD Cowen with a new price target

    TD Cowen downgraded Centene from Buy to Hold and set a new price target of $33.00

    7/21/25 8:26:59 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    SEC Filings

    View All

    Centene Corporation filed SEC Form 8-K: Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    8/15/25 4:29:37 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Centene Corporation

    SCHEDULE 13G/A - CENTENE CORP (0001071739) (Subject)

    8/14/25 4:16:51 PM ET
    $CNC
    Medical Specialities
    Health Care

    Centene Corporation filed SEC Form 8-K: Leadership Update

    8-K - CENTENE CORP (0001071739) (Filer)

    8/4/25 4:36:48 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MHS Serves Announces Recipients of $1.2 Million Investment in Youth Mental Health

    INDIANAPOLIS, Aug. 7, 2025 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE:CNC) company, is proud to announce the recipients of the most recent partnership opportunity from MHS Serves, a $12 million program focused on addressing health disparities across Indiana. Through a collaborative partnership with Indiana Minority Health Coalition (IMHC) and Black Onyx Management managing the program, MHS Serves strives to empower communities through partnerships and innovations focused on health access.

    8/7/25 9:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Superior HealthPlan Invests $18 Million in Over-the-counter Items in 5 Years for Texas Members

    The extra benefits are in addition to regular Medicaid and CHIP coverage, helping support low-income individuals and families. AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE:CNC), announced today it invested $18 million in over-the-counter (OTC) items, a Value-added Service (VAS), for members enrolled in either Medicaid or Children's Health Insurance Program (CHIP) from 2020 through 2024. Value-added Services are extra benefits that help provide additional support for low-income families and individuals across all 254 Texas counties.

    8/5/25 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    Meridian and the Centene Foundation Announce $1 Million Grant to the Food Bank Council of Michigan

    The partnership aims to expand access to fresh food and enhance health outcomes in rural southwest Michigan food deserts DETROIT, July 31, 2025 /PRNewswire/ -- Meridian Health Plan of Michigan, Inc. ("Meridian"), a leading managed care organization in Michigan, and the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE:CNC), announced today a $1 million grant to the Food Bank Council of Michigan (FBCM), a cooperative network of the state's regional food banks dedicated to alleviating hunger and food insecurity. The grant will support efforts in Prosperity Region 8, which includes Berrien, Branch, Calhoun, Cass, Kalamazoo, St. Joseph and Van Buren counties to upgrade curre

    7/31/25 1:45:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    View All

    eHealth Announces CEO Succession

    Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN, Texas, July 29, 2025 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace (the "Company"), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on t

    7/29/25 9:00:00 AM ET
    $CNC
    $EHTH
    Medical Specialities
    Health Care
    Specialty Insurers
    Finance

    NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

    Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

    5/7/25 2:00:00 PM ET
    $CNC
    $LFST
    Medical Specialities
    Health Care
    Medical/Nursing Services

    CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

    ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

    2/24/25 4:15:00 PM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Financials

    Live finance-specific insights

    View All

    CENTENE CORPORATION REPORTS SECOND QUARTER 2025 RESULTS

    -- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $             48,742 Premium and service revenues (in millions) $             42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $                (0.51) Adjusted diluted loss per share (1) $                (0.16) Total cash flow provided by operations (in millions) $              

    7/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION TO HOST 2025 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

    CALL MOVED TO 8AM ET ST. LOUIS, July 22, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 25, 2025, and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7878291 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, 

    7/22/25 8:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS

    -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

    4/25/25 6:00:00 AM ET
    $CNC
    Medical Specialities
    Health Care

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Centene Corporation

    SC 13G - CENTENE CORP (0001071739) (Subject)

    11/14/24 4:06:01 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/13/24 3:02:23 PM ET
    $CNC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Centene Corporation

    SC 13G/A - CENTENE CORP (0001071739) (Subject)

    11/12/24 9:55:15 AM ET
    $CNC
    Medical Specialities
    Health Care